[Bacterial exacerbation of chronic bronchitis: massive or long term antibiotic therapy?].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002908:Chronic Disease; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008134:Long-Term Care; D011743:Pyrimidines / Q000627:therapeutic use; D012008:Recurrence; D013183:Sputum / Q000382:microbiology; D013420:Sulfamethoxazole; D013997:Time Factors; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Bakterielle Exazerbation der chronischen Bronchitis: antibiotische Schubbehandlung oder Langzeittherapie.